Stay updated on AEB1102 in Arginase I Deficiency Clinical Trial
Sign up to get notified when there's something new on the AEB1102 in Arginase I Deficiency Clinical Trial page.

Latest updates to the AEB1102 in Arginase I Deficiency Clinical Trial page
- CheckyesterdayChange DetectedAdded a government funding notice about information possibly not being up to date and updated the revision from v3.4.0 to v3.4.1.SummaryDifference0.5%

- Check8 days agoChange DetectedAdded 'Show glossary', updated the QC-related label to 'Last Update Submitted that Met QC Criteria', and introduced a 'No FEAR Act Data' note with revision tag 'v3.4.0'. Removed the older QC label 'Last Update Submitted that met QC Criteria' and the older 'No FEAR Act data', updating from v3.3.4 to v3.4.0.SummaryDifference0.2%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedRevision metadata updated: added Revision: v3.3.4 and removed Revision: v3.3.3.SummaryDifference0.1%

- Check44 days agoChange DetectedLocations section added with the listed sites (California, Florida, Michigan, New York, Texas, Washington, Ontario) and the page revision updated to v3.3.3; the old location headings and the HHS Vulnerability Disclosure link were removed.SummaryDifference0.9%

- Check72 days agoChange DetectedMinor wording changes in the Publications section and a revision label update were made; these edits do not affect study data or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check79 days agoChange DetectedRemoved the government funding status notice from the page, a non-critical operational detail. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to AEB1102 in Arginase I Deficiency Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AEB1102 in Arginase I Deficiency Clinical Trial page.